VISITAG SURPOINT External Processing Unit
Device Cardiology
PDI 10846835017885
General payments
$13,265
Research payments
$507,857
Through program year 2025, $13,265 in general payments and $507,857 in research payments were reported against VISITAG SURPOINT External Processing Unit (Cardiology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $822 | 32 |
| 2025 | Research | $110,707 | 14 |
| 2024 | General | $771 | 34 |
| 2024 | Research | $110,856 | 1 |
| 2023 | General | $3,208 | 62 |
| 2023 | Research | $20,367 | 8 |
| 2022 | General | $5,108 | 92 |
| 2022 | Research | $37,952 | 14 |
| 2021 | General | $3,356 | 100 |
| 2021 | Research | $227,975 | 137 |
Breakdown
The top 5 of 21 recipients; each share is of general payments naming this product in 2025.
The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 11 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
320 general · 174 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.